Description: ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has more than 9,000 employees and does business in more than 100 countries.
Home Page: www.convatecgroup.com
3 Forbury Place
Reading,
RG1 3JH
United Kingdom
Phone:
44 11 8952 8100
Officers
| Name | Title |
|---|---|
| Mr. Karim Bitar | CEO & Director |
| Mr. Jonathan P. Mason | Group CFO & Director |
| Mr. Donal Balfe | Exec. VP and Chief of Quality & Operations |
| Dr. Divakar Ramakrishnan Ph.D. | Exec. VP & Chief Technology Officer |
| Mr. Mark Reynolds | Director of Investor Relations |
| Ms. Kate Postans | VP of Investor Relations & Corp. Communications |
| Ms. Natalia Kozmina | Exec. VP & Chief HR Officer |
| Mr. Christian Hoengaard | Sr. VP & GM - USA |
| Ms. Kjersti Grimsrud Biotechnology, M.Sc. | Pres & COO of Infusion Care |
| Mr. Supratim Bose | Pres & COO of Global Emerging Markets |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 20.4918 |
|---|---|
| Trailing PE: | 72.375 |
| Price-to-Book MRQ: | 3.6369 |
| Price-to-Sales TTM: | 2.8818 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10000 |